New trials show promise for immune checkpoint blockers in early-stage lung cancer
A dendritic cell (DC) vaccine targeting patient-specific neoantigens to patients with resected non-small cell lung cancer (NSCLC).
https://www.news-medical.net/n....ews/20240418/New-tri
Discover the world at Altruu, The Discovery Engine